{
    "nctId": "NCT00815555",
    "briefTitle": "CYP2D6 Genotyping by AmpliChipTM CYP450 for Tamoxifen-Treated Breast Cancer Patients",
    "officialTitle": "CYP2D6 Genotyping by AmpliChipTM CYP450 for Tamoxifen-Treated Breast Cancer Patients",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 500,
    "primaryOutcomeMeasure": "Tamoxifen efficacy for avoiding breast cancer relapse in relation to CYP2D6 genotype",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female\n* Age \\> 18\n* Treated with Tamoxifen following diagnosis of breast cancer\n\nExclusion Criteria:\n\n* None",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}